Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiaping Zheng

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Liver International : Official Journal of the International Association for the Study of the Liver|January 24, 2024
A Transformer-Based microvascular invasion classifier enhances prognostic stratification in HCC following radiofrequency ablationWentao Wang, Yueyue Wang, Danjun Song, et al.
BMC Cancer|August 31, 2024
Characteristics and patient-reported outcomes of long-term cancer survivors after apatinib-based therapy: an online surveyTingting Zhang, Chao Meng, Wei He, et al.
Medicine|March 21, 2020
Drug-eluting beads transarterial chemoembolization by CalliSpheres is effective and well tolerated in treating intrahepatic cholangiocarcinoma patients: A preliminary result from CTILC studyJun Luo, Jiaping Zheng, Changsheng Shi, et al.
Oncology Research|December 21, 2019
The Comprehensive Analysis of Efficacy and Safety of CalliSpheres<sup>®</sup> Drug-Eluting Beads Transarterial Chemoembolization in 367 Liver Cancer Patients: A Multiple-Center, Cohort StudyZhiyi Peng, Guohong Cao, Qinming Hou, et al.
Translational Cancer Research|February 4, 2022
Efficacy and safety of CalliSpheres<sup>®</sup> drug-eluting beads transarterial chemoembolization in patients with secondary liver cancer: a preliminary result from CTILC studyXia Wu, Shihong Ying, Jing Huang, et al.
Oncology Research|September 28, 2019
Efficacy and Safety of Drug-Eluting Beads Transarterial Chemoembolization by CalliSpheres<sup>®</sup> in 275 Hepatocellular Carcinoma Patients: Results From the Chinese CalliSpheres<sup>®</sup> Transarterial Chemoembolization in Liver Cancer (CTILC) StudyJunhui Sun, Guanhui Zhou, Xiaoxi Xie, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Liver International : Official Journal of the International Association for the Study of the Liver|January 24, 2024
A Transformer-Based microvascular invasion classifier enhances prognostic stratification in HCC following radiofrequency ablationWentao Wang, Yueyue Wang, Danjun Song, et al.
BMC Cancer|August 31, 2024
Characteristics and patient-reported outcomes of long-term cancer survivors after apatinib-based therapy: an online surveyTingting Zhang, Chao Meng, Wei He, et al.
Medicine|March 21, 2020
Drug-eluting beads transarterial chemoembolization by CalliSpheres is effective and well tolerated in treating intrahepatic cholangiocarcinoma patients: A preliminary result from CTILC studyJun Luo, Jiaping Zheng, Changsheng Shi, et al.
Oncology Research|December 21, 2019
The Comprehensive Analysis of Efficacy and Safety of CalliSpheres<sup>®</sup> Drug-Eluting Beads Transarterial Chemoembolization in 367 Liver Cancer Patients: A Multiple-Center, Cohort StudyZhiyi Peng, Guohong Cao, Qinming Hou, et al.
Translational Cancer Research|February 4, 2022
Efficacy and safety of CalliSpheres<sup>®</sup> drug-eluting beads transarterial chemoembolization in patients with secondary liver cancer: a preliminary result from CTILC studyXia Wu, Shihong Ying, Jing Huang, et al.
Oncology Research|September 28, 2019
Efficacy and Safety of Drug-Eluting Beads Transarterial Chemoembolization by CalliSpheres<sup>®</sup> in 275 Hepatocellular Carcinoma Patients: Results From the Chinese CalliSpheres<sup>®</sup> Transarterial Chemoembolization in Liver Cancer (CTILC) StudyJunhui Sun, Guanhui Zhou, Xiaoxi Xie, et al.
Pageof 8